This comprehensive review addresses the critical role of sample quality in cancer molecular testing, a fundamental determinant of diagnostic accuracy and research validity.
This article provides a comprehensive analysis of Variants of Uncertain Significance (VUS) management in cancer genetics for researchers and drug development professionals.
Single-cell RNA sequencing (scRNA-seq) has revolutionized our understanding of tumor heterogeneity by characterizing the complex cellular ecosystems of cancers at unprecedented resolution.
This article provides a comprehensive exploration of contemporary strategies for maximizing the sensitivity of liquid biopsy assays, a critical frontier in precision oncology.
Next-generation sequencing (NGS) has fundamentally transformed oncology, enabling comprehensive genomic profiling that guides precision therapy.
This article provides a comprehensive overview of the current landscape of microsatellite instability (MSI) testing, a critical biomarker for Lynch syndrome screening, prognosis, and predicting response to immunotherapy.
This article provides a comprehensive analysis of current and emerging molecular techniques for Minimal Residual Disease (MRD) monitoring, a critical tool in precision oncology.
Digital PCR (dPCR) represents a third-generation PCR technology that enables absolute, calibration-free quantification of nucleic acids, revolutionizing molecular analysis in oncology.
This article provides a comprehensive overview of Sanger sequencing's pivotal role in single-gene cancer testing for researchers and drug development professionals.
This article provides a comprehensive overview of liquid biopsy and circulating tumor DNA (ctDNA) analysis, tailored for researchers, scientists, and drug development professionals.